TMO - Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 26-30, 2026, in Anaheim, Calif. Spanning specialty diagnostics, quality management and the full diagnostic continuum, Thermo Fisher's presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinic.

Jul 27, 2026 04:30 AM • businesswire.com

Thermo Fisher Scientific Launches Thermo Scientific™ InstaFlux™ to Help Food Microbiology Labs Simplify Workflows in Pathogen and Environmental Testing

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the global launch of Thermo Scientific™ InstaFlux™, an integrated media-on-demand enrichment workflow that helps food microbiology laboratories simplify media preparation, improve productivity and enhance sample traceability. Food testing laboratories face growing pressure to process more samples, meet turnaround expectations and maintain consistent quality while managing staffing constraints, sustainability goals and inc.

Jul 24, 2026 04:30 AM • businesswire.com

Thermo Fisher Scientific Q2 Earnings Call Highlights

Thermo Fisher Scientific NYSE: TMO reported stronger-than-expected second-quarter 2026 results and raised its full-year outlook, citing improving customer activity across end markets, broad-based growth and contributions from recent acquisitions.

Jul 23, 2026 06:07 PM • marketbeat.com

Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript

Jul 23, 2026 11:31 AM • seekingalpha.com

Thermo Fisher Points to Improving End-Market Activity

Thermo Fisher Scientific Inc.  (NYSE:TMO) on Thursday reported second-quarter adjusted earnings of $6.03 per share, beating the street view of $5.71.

Jul 23, 2026 11:07 AM • benzinga.com

TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market

Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.

Jul 23, 2026 07:06 AM • zacks.com

Here's What Key Metrics Tell Us About Thermo Fisher (TMO) Q2 Earnings

Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Jul 23, 2026 06:31 AM • zacks.com

Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $5.71 per share. This compares to earnings of $5.36 per share a year ago.

Jul 23, 2026 04:16 AM • zacks.com

Thermo Fisher beats quarterly estimates as customer demand improves

Thermo Fisher Scientific beat Wall Street estimates for second-quarter profit and revenue on Thursday, as improving ​customer demand lifted sales across all its business ‌segments.

Jul 23, 2026 02:29 AM • reuters.com

Thermo Fisher Scientific Reports Second Quarter 2026 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2026. Second Quarter Highlights Second quarter revenue grew 10% to $11.99 billion Second quarter GAAP diluted earnings per share (EPS) grew 9% to $4.68 Second quarter adjusted EPS grew 13% to $6.03 “We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strateg.

Jul 23, 2026 02:00 AM • businesswire.com

Acumen Wealth Advisors LLC Sells 2,166 Shares of Thermo Fisher Scientific Inc. $TMO

Acumen Wealth Advisors LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 14.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,562 shares of the medical research company's stock after selling 2,166 shares during the period.

Jul 21, 2026 11:40 PM • defenseworld.net

ImmuPharma picks Thermo Fisher to manufacture diabetes drug candidate

ImmuPharma PLC (AIM:IMM, FRA:25I), the drug discovery company, has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon. The US group was chosen after a competitive tender, with its Patheon pharma services arm taking on the drug product workstream.

Jul 21, 2026 10:32 PM • proactiveinvestors.co.uk

Andra AP fonden Purchases 53,990 Shares of Thermo Fisher Scientific Inc. $TMO

Andra AP fonden raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 1,411.9% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,814 shares of the medical research company's stock after acquiring an additional 53,990 shares during the

Jul 20, 2026 11:19 PM • defenseworld.net

Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS

Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Jul 20, 2026 06:16 AM • zacks.com

AIA Group Ltd Cuts Stock Holdings in Thermo Fisher Scientific Inc. $TMO

AIA Group Ltd lowered its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 6.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,693 shares of the medical research company's stock after selling 5,759 shares during

Jul 19, 2026 01:05 AM • defenseworld.net

Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?

TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.

Jul 15, 2026 05:51 AM • zacks.com

TMO Fairly Valued by DCF at $478

On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli

Jul 13, 2026 03:30 AM • gurufocus.com

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h.

Jul 09, 2026 01:00 PM • businesswire.com

Thermo Fisher Q2 Preview: Buy Before The Recovery

Thermo Fisher Scientific Inc. is down 12.2% YTD, underperforming both the S&P 500 and the healthcare sector. Key risks include NIH funding uncertainty, China weakness, slow organic recovery, and integration risk from the $8.9B Clario acquisition. TMO trades at an 18% discount to its 5-year average P/E, reflecting much of the downside already priced in.

Jul 09, 2026 07:29 AM • seekingalpha.com

Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n.

Jul 07, 2026 04:30 AM • businesswire.com

Thermo Fisher price target raised to $600 from $510 at Piper Sandler

$600.00 (was $568.26)

Piper Sandler

Jul 27, 2026 07:09 AM • TheFly

Thermo Fisher price target raised to $650 from $620 at Morgan Stanley

$650.00 (was $568.26)

Morgan Stanley

Jul 24, 2026 04:00 PM • TheFly

Thermo Fisher price target raised to $580 from $490 at RBC Capital

$580.00 (was $561.09)

Dan Leonard · RBC Capital

Jul 24, 2026 08:43 AM • TheFly

Thermo Fisher price target raised to $630 from $585 at Jefferies

$630.00 (was $572.60)

Tycho Peterson · Jefferies

Jul 23, 2026 02:09 PM • TheFly

Thermo Fisher price target lowered to $570 from $575 at Evercore ISI

$570.00 (was $511.31)

Evercore ISI

Jul 06, 2026 08:48 AM • TheFly

Thermo Fisher resumed with a Market Perform at Bernstein

$520.00 (was $505.75)

Bernstein

Jun 26, 2026 06:26 AM • TheFly

Thermo Fisher initiated with a Neutral at Piper Sandler

$510.00 (was $482.04)

Piper Sandler

Jun 11, 2026 05:52 AM • TheFly

HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold

$540.00 (was $482.08)

Sidharth Sahoo · HSBC

Jun 03, 2026 03:12 AM • StreetInsider

Thermo Fisher resumed with a Sector Perform at RBC Capital

$490.00 (was $448.21)

RBC Capital

May 14, 2026 04:21 PM • TheFly

Thermo Fisher price target lowered to $620 from $670 at Morgan Stanley

$620.00 (was $472.23)

Kallum Titchmarsh · Morgan Stanley

Apr 27, 2026 08:33 AM • TheFly

Thermo Fisher price target lowered to $600 from $700 at Stifel

$600.00 (was $467.47)

Daniel Arias · Stifel Nicolaus

Apr 24, 2026 08:16 AM • TheFly

Thermo Fisher price target lowered to $639 from $653 at Baird

$639.00 (was $466.70)

Catherine Ramsey Schulte · Robert W. Baird

Apr 24, 2026 06:34 AM • TheFly

Thermo Fisher price target raised to $615 from $590 at UBS

$615.00 (was $579.86)

UBS

Jan 30, 2026 09:25 AM • TheFly

Thermo Fisher Scientific (TMO) PT Lowered to $683 at TD Cowen

$683.00 (was $580.09)

Wells Fargo

Jan 30, 2026 09:08 AM • StreetInsider

Thermo Fisher price target raised to $653 from $645 at Baird

$653.00 (was $583.12)

Robert W. Baird

Jan 30, 2026 07:27 AM • TheFly

Thermo Fisher price target raised to $650 from $625 at Barclays

$650.00 (was $592.16)

Barclays

Jan 30, 2026 05:36 AM • TheFly

Thermo Fisher price target raised to $700 from $583 at Stifel

$700.00 (was $606.50)

Daniel Arias · Stifel Nicolaus

Jan 09, 2026 07:36 AM • TheFly

Thermo Fisher price target raised to $650 from $610 at Evercore ISI

$650.00 (was $605.83)

Vijay Kumar · Evercore ISI

Jan 05, 2026 09:55 AM • TheFly

Thermo Fisher price target raised to $675 from $635 at Wells Fargo

$675.00 (was $571.99)

Wells Fargo

Dec 15, 2025 06:30 AM • TheFly

Thermo Fisher initiated with a Buy at Goldman Sachs

$685.00 (was $568.21)

Evie Koslosky · Goldman Sachs

Dec 09, 2025 04:27 AM • TheFly